Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.
Mol Cancer Res. 2019 Jul;17(7):1531-1544. doi: 10.1158/1541-7786.MCR-18-0315. Epub 2019 Mar 18.
Mol Cancer Res. 2019.
PMID: 30885992
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.
Feldinger K, Generali D, Kramer-Marek G, Gijsen M, Ng TB, Wong JH, Strina C, Cappelletti M, Andreis D, Li JL, Bridges E, Turley H, Leek R, Roxanis I, Capala J, Murphy G, Harris AL, Kong A.
Feldinger K, et al.
Oncotarget. 2014 Aug 30;5(16):6633-46. doi: 10.18632/oncotarget.1955.
Oncotarget. 2014.
PMID: 24952873
Free PMC article.
Item in Clipboard
Profile of neratinib and its potential in the treatment of breast cancer.
Feldinger K, Kong A.
Feldinger K, et al.
Breast Cancer (Dove Med Press). 2015 Jun 9;7:147-62. doi: 10.2147/BCTT.S54414. eCollection 2015.
Breast Cancer (Dove Med Press). 2015.
PMID: 26089701
Free PMC article.
Review.
Item in Clipboard
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models.
Arshad M, Azad A, Chan PYK, Vigneswara V, Feldinger K, Nafi SNM, Laporte-Maguire E, De Santo C, Zuo J, Shaaban AM, Kong A.
Arshad M, et al. Among authors: feldinger k.
Br J Cancer. 2024 Jun;130(12):1990-2002. doi: 10.1038/s41416-024-02665-z. Epub 2024 Apr 10.
Br J Cancer. 2024.
PMID: 38600326
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.